14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
THC vs EHC: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Tenet Healthcare Corporation New (THC) is the stronger overall head-to-head candidate over Encompass Health Corporation (EHC) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). THC carries a Unified Composite Score of 50.3/100 (HOLD) at $263.19 (13.0x Forward P/E, 19.1% operating margin), whereas EHC carries 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin).
Composite vs. Pillar Nuance: While EHC currently prints a higher short-term Unified Composite Score (52.0/100 HOLD vs. THC 50.3/100 HOLD), THC captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (19.1% vs. 18.4% operating margin) and revenue trajectory (+6.5% vs. +8.9% YoY).
Competes within the Medical Care Facilities value chain with $21.0B market capitalization and 19.1% operating margin.
OpEx & R&D Reinvestment23.4% of Rev ($5.18B)
90D Engineering Disclosures0 Published
EHC Moat ProfileScale & Operating Efficiency Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $13.0B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment25.7% of Rev ($1.63B)
90D Engineering Disclosures0 Published
Investor FAQ THC vs EHC Key Questions & Quantitative Answers
As of Nov 20, 2026, Tenet Healthcare Corporation New (THC) is the stronger overall head-to-head candidate over Encompass Health Corporation (EHC) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). THC carries a Unified Composite Score of 50.3/100 (HOLD) at $263.19 (13.0x Forward P/E, 19.1% operating margin), whereas EHC carries 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin). Composite vs. Pillar Nuance: While EHC currently prints a higher short-term Unified Composite Score (52.0/100 HOLD vs. THC 50.3/100 HOLD), THC captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (19.1% vs. 18.4% operating margin) and revenue trajectory (+6.5% vs. +8.9% YoY).
THC leads the Growth & Scale pillar: THC posts +6.5% YoY revenue growth and +221.5% YoY earnings growth on $22.2B TTM revenue (42.5% gross margin, 19.1% operating margin), compared with EHC at +8.9% YoY revenue growth and +21.6% YoY earnings growth on $6.34B TTM revenue (44.1% gross margin, 18.4% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), THC cumulative revenue shifted +16.4% while EHC shifted +38.8%. In operating R&D and SG&A reinvestment, THC deploys 23.4% of Rev ($5.18B) (0 90-day corporate R&D disclosures) versus 25.7% of Rev ($1.63B) (0 disclosures) for EHC.
THC screens cheaper on headline valuation multiples. THC trades at 13.0x Forward P/E, 7.7x Trailing P/E, 1.79x PEG, and 1.4x EV/Revenue (15.0% FCF margin), whereas EHC trades at 19.4x Forward P/E, 21.2x Trailing P/E, 0.41x PEG, and 2.5x EV/Revenue (7.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against THC (41.7% ROE) versus EHC (25.1% ROE) capital efficiency.
In options market volatility and institutional positioning, THC carries 39.9% implied volatility (4th %ile, Compressed (<25th %ile)), a 0.92x (Balanced) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.53β · 44% Vol realized risk). By comparison, EHC carries 27.0% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.25x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.10β · 40% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.